Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Organ-sparing treatment of advanced bladder cancer: paclitaxel as a radiosensitizer.

Organ-sparing treatment of advanced bladder cancer: paclitaxel as a radiosensitizer. Strahlenther Onkol. 2007 Apr; 183(4):177-83.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.